Clinical Trial Update: An Open-label Extension Study to Evaluate Long-term Efficacy and Safety of Odevixibat in Children With Biliary Atresia [Phase 3]

View source ↗

Summary

Open-label extension study to evaluate long-term efficacy and safety of odevixibat in children with biliary atresia, currently enrolling by invitation in Phase …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Atresia

Drugs mentioned

• Odevixibat (odevixibat)

Snippet

Sponsor: Albireo, an Ipsen Company | Conditions: Biliary Atresia | Phase 3 | Status: ENROLLING_BY_INVITATION